Table 2 Postoperative nausea and vomiting in hospital and after discharge
| Â | Control (n = 67) | Ramosetron (n = 67) | P value |
|---|---|---|---|
Postoperative 0–0.5 h | |||
 Nausea | 9 (13%) | 4 (6%) | 0.144 |
 Vomiting | 2 (3%) | 0 (0%) | 0.496 |
 Nausea, VNRS | 8 (22) | 3 (11) | 0.110 |
 IV ramosetron | 5 (8%) | 1 (2%) | 0.208 |
Postoperative 0.5–3 h | |||
 Nausea | 16 (24%) | 17 (25%) | 0.841 |
 Vomiting | 1 (2%) | 2 (3%) | 1.000 |
 Nausea, VNRS | 7 (18) | 6 (13) | 0.736 |
 IV ramosetron | 3 (5%) | 2 (3%) | 1.000 |
 IV metoclopramide | 2 (3%) | 0 (0%) | 0.496 |
Post-discharge 24 h | |||
 Nausea | 22 (33%) | 9 (13%) | 0.008 |
 Vomiting | 1 (2%) | 2 (3%) | 1.000 |
 Nausea, VNRS | 14 (23) | 5 (16) | 0.011 |
 Oral metoclopramide | 12 (18%) | 4 (6%) | 0.033 |
 Oral metoclopramide (mg) | 2.4 (5.8) | 0.6 (2.4) | 0.021 |
Post-discharge 24–48 h | |||
 Nausea | 9 (13%) | 5 (8%) | 0.259 |
 Vomiting | 0 (0%) | 1 (2%) | 1.000 |
 Nausea, VNRS | 5 (14) | 4 (15) | 0.673 |
 Oral metoclopramide | 4 (6%) | 1 (2%) | 0.365 |
 Oral metoclopramide (mg) | 0.9 (4.2) | 0.1 (1.2) | 0.162 |
 Patient satisfaction score | 86 (16) | 95 (9) | <0.001 |